Milestone Scientific Schedules 2021 Fiscal Year Financial Results and Business Update Conference Call
Milestone Scientific (NYSE:MLSS) has announced a conference call set for April 1, 2022, at 8:30 AM ET to discuss its financial results for the fiscal year ending December 31, 2021. The call will cover corporate progress and developments. Investors can join via telephone or access a webcast on the company’s Investor Relations page. An audio replay will be available until April 15, 2022. Milestone Scientific specializes in computerized drug delivery instruments aimed at providing painless and precise injections, enhancing patient comfort and safety.
- None.
- None.
ROSELAND, N.J., March 29, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, April 1, 2022 to discuss the company’s financial results for the 2021 fiscal year ended December 31, 2021, as well as the company’s corporate progress and other developments.
The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 639488. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2306/45018 or on the Investor Relations section of the Company’s website at https://www.milestonescientific.com/investors.
An audio replay of the call will be available through April 15, 2022, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and by entering the access code: 45018.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS), a technology focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.
SOURCE: Milestone Scientific Inc.
Contact:
David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020
FAQ
When will Milestone Scientific discuss its 2021 financial results?
How can I access the Milestone Scientific conference call?
Is there a way to listen to the replay of the Milestone Scientific conference call?
What is Milestone Scientific's main focus?
